跳至主要内容
临床试验/NCT04327479
NCT04327479已完成不适用

Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection

University Hospital, Essen1 个研究点 分布在 1 个国家目标入组 728 人开始时间: 2020年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
728
试验地点
1
主要终点
All-cause mortality

研究概览

简要总结

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with suspected SARS-CoV2/Covid-19 infection

排除标准

  • Unwillingness to participate

结局指标

主要结局

All-cause mortality

时间窗: During 1 year follow-up

mortality of any cause

次要结局

  • Major adverse cardiovascular events(During 1 year follow-up)
  • 30-day mortality(Within 30 days after inclusion)

研究者

发起方
University Hospital, Essen
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验